EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Workup of Encephalopathy in Patients Receiving Cancer Immunotherapy

Neil Sielski

Seminars in Neurology · 2026-10-30

DOI: 10.1055/a-2979-5558 ↗
AbstractBibliografische Angaben

Abstract

Abstract Cancer immunotherapy has transformed many areas of oncologic care. Neurological immune-related adverse events, particularly encephalopathy, represent potentially life-threatening complications requiring prompt recognition and intervention. Encephalopathic syndromes occur across immunotherapy modalities, including immune checkpoint inhibitors, chimeric antigen receptor-T cell therapy, and bispecific antibodies. The diagnostic challenge lies in distinguishing immune-mediated neurotoxicity from infection, metabolic derangements, disease progression, and paraneoplastic syndromes. A systematic evaluation incorporates detailed clinical assessment with neuroimaging, cerebrospinal fluid analysis, electroencephalography, and autoimmune antibody testing as appropriate. This review provides a practical approach to recognizing and assessing encephalopathy in patients receiving immunotherapy. Early multidisciplinary collaboration between neurology and oncology teams is critical for recognizing symptoms, managing adverse effects, and guiding cancer-directed treatment.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →